Vaccinia Virus Strain New York City Board Of Health Live Antigen
Vaccinia Virus Strain New York City Board Of Health Live Antigen Uses, Dosage, Side Effects, Food Interaction and all others data.
The New York City Board of Health strain of Vaccinia is a viral strain used as a component of some smallpox vaccinations. ACAM2000, a percutaneously administered smallpox vaccine that was approved by the FDA in 2007, contains live antigens of this strain.
Table Of contents
| Trade Name | Vaccinia Virus Strain New York City Board Of Health Live Antigen |
| Generic | Smallpox (Vaccinia) Vaccine, Live |
| Smallpox (Vaccinia) Vaccine, Live Other Names | Smallpox (vaccinia) vaccine, live, Smallpox vaccine, Vaccinia virus live antigen, B, Vaccinia virus strain new york city board of health live (attenuated) antigen, Vaccinia virus strain new york city board of health live antigen, Vaccininum, Vaccinotoxinum |
| Type | |
| Groups | Approved |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Uses
The live antigen of the New York City Board of Health strain of Vaccinia is indicated (within the ACAM2000 formulation) for active immunization against smallpox disease in patients determined to be at high risk of contracting smallpox infection.
Vaccinia Virus Strain New York City Board Of Health Live Antigen is also used to associated treatment for these conditions: Smallpox
Food Interaction
No interactions found.Innovators Monograph
You find simplified version here Vaccinia Virus Strain New York City Board Of Health Live Antigen
